Literature DB >> 28787699

lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway.

Yan Zhang1, Cheng Xiang2, Yuling Wang3, Yuanyuan Duan4, Ci Liu1, Yongli Jin1, Yajing Zhang1.   

Abstract

Accumulating evidence demonstrates that lncRNAs play important roles in regulating gene expression and are involved in various pathological processes. In our present study, we firstly evaluated lncRNA LINC00152 and EGFR expressions by ISH or IHC methods, and analyzed the correlation between LINC00152 and EGFR with RT-PCR. lncRNA LINC00152 of NSCLC tissues were significantly up-regulation compared with adjacent normal tissues and positively correlated with EGPR. The further cell experiments demonstrated that Linc00152 knockdown had effects of suppression cell proliferation, invasion and migration abilities and improving cell apoptosis and G1 phase rates in both A549 and H1299 cell lines. In the mechanism study, the results were shown that EGFR, PI3K, AKT, Fibronectin and Vimentin proteins expressions were significantly reduced and P21 protein expression was significantly increased in Linc00152 knockdown groups. Our results suggested lncRNA LINC00152 knock-down had anti-tumor effects via EGFR/PI3K/AKT pathway.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  A549; AKT; EGFR; H1299; PI3K; lncRNA LINC00152

Mesh:

Substances:

Year:  2017        PMID: 28787699     DOI: 10.1016/j.biopha.2017.07.120

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Long non-coding RNA CYTOR regulates proliferation and metastasis of colon cancer cells through regulating miRNA-105/PTEN axis.

Authors:  Yi Zhang; Weidong Jin; Dandan Ma; Jun Cao; Tao Fu; Zhaolin Zhang; Yang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

2.  Role of LINC00152 in non-small cell lung cancer.

Authors:  Hong Yu; Shu-Bin Li
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

Review 3.  PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.

Authors:  Rosalin Mishra; Hima Patel; Samar Alanazi; Mary Kate Kilroy; Joan T Garrett
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

Review 4.  Genome-wide analysis reveals the emerging roles of long non-coding RNAs in cancer.

Authors:  Xiaoxia Ren
Journal:  Oncol Lett       Date:  2019-11-22       Impact factor: 2.967

Review 5.  Dysregulations of long non-coding RNAs - The emerging "lnc" in environmental carcinogenesis.

Authors:  Po-Shun Wang; Zhishan Wang; Chengfeng Yang
Journal:  Semin Cancer Biol       Date:  2021-04-03       Impact factor: 15.707

Review 6.  Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.

Authors:  Zeinab Moafian; Abolfazl Maghrouni; Arash Soltani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2021-05-31       Impact factor: 2.316

Review 7.  [Advances in Long Non-coding RNAs on Resistant to EGFR-TKIs 
in Non-small Cell Lung Cancer].

Authors:  Shubin Li; Hong Yu; Gengyue Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-02-20

8.  Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis.

Authors:  Orsolya Galamb; Alexandra Kalmár; Anna Sebestyén; Titanilla Dankó; Csilla Kriston; István Fűri; Péter Hollósi; István Csabai; Barnabás Wichmann; Tibor Krenács; Barbara Kinga Barták; Zsófia Brigitta Nagy; Sára Zsigrai; Gábor Barna; Zsolt Tulassay; Péter Igaz; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2020-04-20       Impact factor: 3.201

9.  LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation.

Authors:  Yong Huang; Hui Luo; Fang Li; Yun'e Yang; Guangsheng Ou; Xiaolong Ye; Nianchu Li
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

10.  CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.

Authors:  Yichuan Chen; Jingqun Tang; Ting Lu; Fang Liu
Journal:  Thorac Cancer       Date:  2020-05-12       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.